Search for: "Abbvie, Inc." Results 41 - 60 of 143
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2020, 1:16 pm by Angela Mauroni
The pharmaceutical company AbbVie, Inc. has reached a settlement agreement with California over allegations that it violated the state’s Insurance Frauds Prevention Act. [read post]
11 May 2020, 3:59 am by Deb Givens
  Drugmaker AbbVie Inc. has won U.S. antitrust approval to buy Botox maker Allergan, a blockbuster $63 billion deal when it was announced last year, the companies said on Tuesday. [read post]
12 Apr 2020, 6:03 am by Kluwer Patent blogger
” Israel invoked an emergency patent-suspension clause, allowing it to import a generic version of anti-viral drug Kaletra produced by AbbVie Inc. [read post]
30 Sep 2019, 6:08 am by Deb Givens
Federal Trade Commission (FTC) has requested for more information from AbbVie Inc and botox maker Allergan Plc on their $63 billion deal, the companies said on Friday. [read post]
23 Sep 2019, 6:31 am by Deb Givens
Bristol-Myers Squibb’s $74 billion buyout of Celgene Corp. and AbbVie Inc. [read post]
24 Jul 2019, 6:22 am by Philipp Widera
Legal background regarding Arrow-declarations The underlying jurisdiction was established in Arrow Generics v Merck & Co Inc [2007] FSR 39 and approved by the Court of Appeal in Fujifilm v AbbVie [2017] EWCA Civ. 1. [read post]
7 Mar 2019, 12:29 pm by Schachtman
One litigation that showcases the use and misuse of the ASA Statement arose from claims that AbbVie, Inc. [read post]
7 Dec 2018, 2:23 pm by Lawrence B. Ebert
TevaParenteral Meds., Inc., 689 F.3d 1368, 1376 (Fed. [read post]
9 Aug 2018, 4:54 pm by Kevin LaCroix
In the nearly three years since the Delaware Court of Chancery first signaled its hostility to the proliferation of so-called disclosure-only merger lawsuits (culminating in the landmark In re Trulia, Inc. [read post]
29 Jun 2018, 3:08 am by Brian Cordery
Brian Corderyby Craig Lumb After a decade-long hiatus, so-called Arrow declarations are now firmly back in fashion after the Court of Appeal’s judgment last year in Fujifilm Kyowa Kirin Biologics Co, Ltd v Abbvie Biotechnology Ltd & Anor [2017] EWCA Civ 1. [read post]
25 May 2018, 9:27 am
The case of Edwards Lifesciences LLC v Boston Scientific Scimed Inc & Ors [2018] EWHC 1256 (Pat) handed down yesterday, is a little more nuanced. [read post]